跳转至内容
Merck

B7273

Sigma-Aldrich

苯扎贝特

≥98%, solid

别名:

2- [4- [2-(4-氯苯甲酰胺基)苄]苯氧基] -2-甲基丙酸

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C19H20ClNO4
CAS号:
分子量:
361.82
EC號碼:
MDL號碼:
分類程式碼代碼:
12352200
PubChem物質ID:
NACRES:
NA.77

品質等級

化驗

≥98%

形狀

solid

溶解度

DMF: soluble
deionized water: insoluble
methanol: soluble

起源

Roche

SMILES 字串

CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(O)=O

InChI

1S/C19H20ClNO4/c1-19(2,18(23)24)25-16-9-3-13(4-10-16)11-12-21-17(22)14-5-7-15(20)8-6-14/h3-10H,11-12H2,1-2H3,(H,21,22)(H,23,24)

InChI 密鑰

IIBYAHWJQTYFKB-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

應用

苯扎贝特已被用于:
  • 小鼠标准饲料 (SD) 中的补充剂,用于研究其对糖尿病的影响
  • 评估其对丙型肝炎病毒 (HCV) 组装和分泌的影响
  • 评估其对斑马鱼性腺类固醇生成和精子生成的影响,也用作 HPLC 的标准

生化/生理作用

苯扎贝特具有抑制 HCV 组装和分泌的能力。它用于治疗血脂异常。
过氧化物酶体增殖物激活受体(PPAR)是类固醇核受体超家族成员之一。苯扎贝特是过氧化物酶体增殖物激活受体活化剂,用于PPARα、PPARδ和PPARγ。脂蛋白脂酶(LPL)激活剂。
PPARgamma激动剂(包括苯扎贝特)在抑制RSV感染期间的炎症反应中具有有益作用,因此在重度RSV感染过程中可能具有临床疗效。

特點和優勢

该化合物由Roche开发。要浏览其他药物开发化合物和批准的药物/候选药物列表,单击此处
这种化合物是基因调控研究的特色产品。点击此处发现更多特色基因调控产品。在sigma.com/discover-bsm可了解更多关于生物活性小分子的其他研究领域。

象形圖

Exclamation mark

訊號詞

Warning

危險聲明

危險分類

Acute Tox. 4 Oral

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 1

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

dust mask type N95 (US), Eyeshields, Gloves


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice
Franko A, et al.
Molecular Metabolism, 6(3), 256-266 (2017)
Marc Engelen et al.
PloS one, 7(7), e41013-e41013 (2012-08-23)
X-linked adrenoleukodystrophy (X-ALD) is caused by mutations in the ABCD1 gene and is characterized by impaired beta-oxidation of very-long-chain fatty acids (VLCFA) and subsequent VLCFA accumulation in tissues. In adulthood X-ALD most commonly manifests as a gradually progressive myelopathy, (adrenomyeloneuropathy;
Bezafibrate improves insulin sensitivity and metabolic flexibility in STZ-induced diabetic mice
Franko A, et al.
Diabetes, 65(9), 2540-2552 (2016)
Akira Honda et al.
Hepatology (Baltimore, Md.), 57(5), 1931-1941 (2012-08-23)
Bezafibrate is a widely used hypolipidemic agent and is known as a ligand of the peroxisome proliferator-activated receptors (PPARs). Recently this agent has come to be recognized as a potential anticholestatic medicine for the treatment of primary biliary cirrhosis (PBC)
Bezafibrate, a lipid-lowering pharmaceutical, as a potential endocrine disruptor in male zebrafish (Danio rerio)
Velasco-Santamaria YM, et al.
Aquatic Toxicology (Amsterdam, Netherlands), 105(1-2), 107-118 (2011)

商品

We offer a variety of small molecule research tools, such as transcription factor modulators, inhibitors of chromatin modifying enzymes, and agonists/antagonists for target identification and validation in gene regulation research; a selection of these research tools is shown below.

We offer a variety of small molecule research tools, such as transcription factor modulators, inhibitors of chromatin modifying enzymes, and agonists/antagonists for target identification and validation in gene regulation research; a selection of these research tools is shown below.

We offer a variety of small molecule research tools, such as transcription factor modulators, inhibitors of chromatin modifying enzymes, and agonists/antagonists for target identification and validation in gene regulation research; a selection of these research tools is shown below.

We offer a variety of small molecule research tools, such as transcription factor modulators, inhibitors of chromatin modifying enzymes, and agonists/antagonists for target identification and validation in gene regulation research; a selection of these research tools is shown below.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门